Literature DB >> 11197695

Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit.

D Huang1, M R Cancilla, G Morahan.   

Abstract

Owing to the importance of interleukin (IL)-12 in regulating immune responses, we have determined the complete genomic sequence and organization of the gene encoding its p40 subunit. The genomic sequence was determined and was compared to cDNA sequences to derive exon/intron boundaries. Unusually, both the first and last of the eight exons of this gene are not translated. An extensive search identified several polymorphisms in IL-12p40, including repeat elements in introns 2 and 4 and a polymorphic Taql site in the 3'UTR. However, no polymorphisms were found which could result in amino acid substitutions. This finding places constraints on any preferential involvement of alleles of IL-12p40 in contributing to autoimmune, inflammatory or infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197695     DOI: 10.1038/sj.gene.6363720

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  28 in total

1.  Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene.

Authors:  N Martinez-Pomar; S Raga; J Ferrer; J Pons; I Munoz-Saa; M-R Julia; J de Gracia; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Mutation detection using mass spectrometric separation of tiny oligonucleotide fragments.

Authors:  Colleen Elso; Brendan Toohey; Gavin E Reid; Karl Poetter; Richard J Simpson; Simon J Foote
Journal:  Genome Res       Date:  2002-09       Impact factor: 9.043

3.  The IL12B gene is associated with asthma.

Authors:  Adrienne G Randolph; Christoph Lange; Edwin K Silverman; Ross Lazarus; Eric S Silverman; Benjamin Raby; Alison Brown; Al Ozonoff; Brent Richter; Scott T Weiss
Journal:  Am J Hum Genet       Date:  2004-08-20       Impact factor: 11.025

4.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

5.  Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates.

Authors:  G Bokodi; L Derzbach; I Bányász; T Tulassay; B Vásárhelyi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-06-05       Impact factor: 5.747

6.  Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Vuslat Yilmaz; Veysi Demirbilek; Candan Gürses; Sibel P Yentür; Serap Uysal; Zuhal Yapici; Gülden Yilmaz; Aaron Muncey; Ozlem Cokar; Emel Onal; Aysen Gökyiğit; Güher Saruhan-Direskeneli
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

7.  Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.

Authors:  G Morahan; E McKinnon; J Berry; B Browning; C Julier; F Pociot; I James
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

8.  Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis.

Authors:  Huilong Chen; Sheng Cheng; Jianmiao Wang; Chao Cao; Hansvin Bunjhoo; Weining Xiong; Yongjian Xu
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

9.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.